Maxine Gowen, Director at Akebia Therapeutics, Inc. (AKBA), bought 1,300 shares at $11.82 ($15K) on 2014-11-13, disclosed to the SEC on 2014-11-14.
Open-market purchase of $15k AKBA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TRVN | BUY | 2019-02-05 | $51K | — | Filing → |
| TRVN | BUY | 2016-11-09 | $103K | — | Filing → |
| IDRA | BUY | 2016-10-05 | $11K | — | Filing → |